Back to search
Trypanosoma Cruzi Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Trypanosoma Cruzi Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Trypanosoma Cruzi Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is to investigate the ability of LXE408 to clear or reduce the level of parasites in the blood of people with chronic Chagas disease. Participants mu…
Chagas disease (CD) is the most significant endemic zoonosis in Argentina. Two-thirds of affected individuals live in urban areas but only 10% globally are awar…
Chagas disease is an endemic problem in Latin America, where millions of people are chronically infected with T. cruzi. Recently, it was assumed to have clinica…
Chagas disease, a parasitic infection caused by Trypanosoma cruzi, is endemic in much of Latin America and affects people throughout the world. Currently treatm…
The goal of this observational study is to improve access to diagnosis and treatment for chronic Trypanosoma cruzi infection among university students of all ag…
This is an observational study in which data from women with Chagas disease who will take or have already taken nifurtimox during pregnancy and the impact on th…